XML 63 R43.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)
12 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Selected Information by Business Segment
Selected information by business segment is presented below:
(In thousands)
2018
 
2017
 
2016
Net revenues
 
 
 
 
 
Japan
$
68,172

 
$
74,695

 
$
84,270

EMEA
183,301

 
198,396

 
204,192

North America Plasma
333,831

 
309,718

 
279,803

All Other
324,013

 
316,771

 
342,249

Net revenues before foreign exchange impact
909,317

 
899,580

 
910,515

Effect of exchange rates
(5,394
)
 
(13,464
)
 
(1,683
)
Net revenues
$
903,923

 
$
886,116

 
$
908,832

(In thousands)
2018
 
2017
 
2016
Segment operating income
 
 
 
 
 
Japan
$
37,243

 
$
39,892

 
$
43,619

EMEA
62,696

 
65,689

 
63,665

North America Plasma
119,003

 
98,254

 
109,220

All Other
128,945

 
127,834

 
127,493

Segment operating income
347,887

 
331,669

 
343,997

  Corporate operating expenses
(220,699
)
 
(211,481
)
 
(227,839
)
  Effect of exchange rates
4,059

 
(4,772
)
 
3,546

Restructuring and turnaround costs
(44,125
)
 
(34,337
)
 
(42,185
)
Deal amortization
(26,013
)
 
(27,107
)
 
(28,958
)
Impairment of assets
(1,941
)
 
(73,353
)
 
(97,230
)
Legal charges(1)
(3,011
)
 

 

Contingent consideration income

 

 
4,727

Operating income (loss)
$
56,157

 
$
(19,381
)
 
$
(43,942
)
(1) Reflects net impact of settlement charges associated with the fiscal 2017 voluntary whole blood collection kits recall.
(In thousands)
2018
 
2017
 
2016
Depreciation and amortization
 
 
 
 
 
Japan
$
486

 
$
827

 
$
774

EMEA
4,464

 
4,255

 
5,146

North America Plasma
16,060

 
13,022

 
12,944

All Other
68,237

 
71,629

 
71,047

Total depreciation and amortization (excluding impairment charges)
$
89,247

 
$
89,733

 
$
89,911

(In thousands)
March 31,
2018
 
April 1,
2017
 
April 2,
2016
Long-lived assets(2)
 
 
 
 
 
Japan
$
26,640

 
$
21,412

 
$
33,159

EMEA
74,783

 
63,854

 
63,861

North America Plasma
91,815

 
142,164

 
116,001

All Other
138,918

 
96,432

 
124,613

Total long-lived assets
$
332,156

 
$
323,862

 
$
337,634

(2) Long-lived assets are comprised of property, plant and equipment.
Selected information by principle operating regions is presented below:
(Dollars in thousands)
2018
 
2017
 
2016
Net Revenues
 
 
 
 
 
United States
$
548,731

 
$
522,686

 
$
519,440

Japan
67,319

 
79,266

 
81,411

Europe
164,226

 
166,007

 
187,725

Asia
115,127

 
109,858

 
111,758

Other
8,520

 
8,299

 
8,498

Net revenues
$
903,923

 
$
886,116

 
$
908,832

(Dollars in thousands)
March 31,
2018
 
April 1,
2017
 
April 2,
2016
Long-lived assets(2)
 
 
 
 
 
United States
$
236,603

 
$
241,610

 
$
231,744

Japan
1,511

 
1,691

 
2,022

Europe
13,696

 
12,952

 
18,672

Asia
36,431

 
34,174

 
40,235

Other
43,915

 
33,435

 
44,961

Total long-lived assets
$
332,156

 
$
323,862

 
$
337,634

(2) Long-lived assets are comprised of property, plant and equipment.
Schedule of Revenues by Product Line
Net revenues by business unit are as follows:
(Dollars in thousands)
2018
 
2017
 
2016
Plasma
435,956

 
410,727

 
381,776

Blood Center
284,902

 
303,890

 
355,108

Cell Processing
107,562

 
105,376

 
112,483

Hemostasis Management
75,503

 
66,123

 
59,465

Net revenues
$
903,923

 
$
886,116

 
$
908,832